"Designing Growth Strategies is in our DNA"

U.S. Mycoplasma Testing Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments and Reagents & Kits), By Testing Method (PCR-based, Culture-based, and Others), By Application (Cell Culture, Vaccine Testing, Virus Testing, and Others), and By End-user (Biopharmaceutical & Biotechnology Companies, Cell Banks, Contract Research & Contract Manufacturing Organizations, and Others), and Country Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108747

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 5.4% from 2023 to 2030

Unit

Value (USD Million)

Segmentations

By Product

  • Instruments
  • Reagents & Kits

By Testing Method

  • PCR-based
  • Culture-based
  • Others

By Application

  • Cell Culture
  • Vaccine Testing
  • Virus Testing
  • Others

By End-user

  • Biopharmaceutical & Biotechnology Companies
  • Cell Banks
  • Contract Research Organizations & Contract Manufacturing Organizations
  • Others
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann